ConSynance Therapeutics Announces U.S. FDA Grants Rare Pediatric Disease Designation to CSTI-500, a Potential First-in-Class Therapy for Prader-Willi Syndrome
July 24, 2024 10:00 ET
|
ConSynance Therapeutics
FDA awards ConSynance's CSTI-500 Rare Pediatric Disease Designation for innovative Prader-Willi Syndrome treatment.
RPD STOCKHOLDER ALERT: Rapid7, Inc. (Nasdaq:RPD) Shareholders are Notified that BFA Law is Investigating a Potential Merger of the Company and are Urged to Contact the Firm
July 24, 2024 06:08 ET
|
Bleichmar Fonti & Auld
Rapid7 shareholders are encouraged to contact BFA Law about its investigation into potential claims for breach of fiduciary duty against Rapid7, Inc.
RPD ONGOING INVESTIGATION: BFA Law Reminds Rapid7, Inc. (Nasdaq:RPD) Stockholders to Contact Us about Continuing Investigation into a Potential Acquisition
July 22, 2024 06:39 ET
|
Bleichmar Fonti & Auld
Rapid7 shareholders are encouraged to contact BFA Law about its investigation into potential claims for breach of fiduciary duty against Rapid7, Inc.
RPD LEGAL NEWS: BFA Law Announces that it is Reviewing Claims on Behalf of Rapid7, Inc. (Nasdaq:RPD) Stockholders Related to a Potential Acquisition of the Company
July 20, 2024 06:07 ET
|
Bleichmar Fonti & Auld
Rapid7 shareholders are encouraged to contact BFA Law about its investigation into potential claims for breach of fiduciary duty against Rapid7, Inc.
RPD SHAREHOLDER NOTICE: BFA Law is Inspecting Claims on Behalf of Rapid7, Inc. (Nasdaq:RPD) Investors Related to a Potential Acquisition and Encourages Shareholders to Contact the Firm
July 18, 2024 07:49 ET
|
Bleichmar Fonti & Auld
Rapid7 Investors are encouraged to contact BFA Law about its investigation into potential claims for breach of fiduciary duty against Rapid7, Inc.
RPD SHAREHOLDER NOTIFICATION: Rapid7, Inc. (Nasdaq:RPD) Investors are Urged to Contact BFA Law about Investigation into the Company’s Acquisition Price
July 16, 2024 06:07 ET
|
Bleichmar Fonti & Auld
Rapid7 Shareholders are encouraged to contact BFA Law about its investigation into potential claims for breach of fiduciary duty against Rapid7, Inc.
RPD INVESTOR NOTICE: Rapid7, Inc. (Nasdaq:RPD) Shareholders are Notified to Contact BFA Law about Investigation into the Company’s Acquisition Price
July 13, 2024 06:01 ET
|
Bleichmar Fonti & Auld
Rapid7 Shareholders are encouraged to contact BFA Law about its investigation into potential claims for breach of fiduciary duty against Rapid7, Inc.
RPD INVESTIGATION NEWS: Rapid7, Inc. (Nasdaq:RPD) Shareholders are Notified to Contact BFA Law about Investigation into the Company’s Acquisition Price
July 11, 2024 07:04 ET
|
Bleichmar Fonti & Auld
Rapid7 Shareholders are encouraged to contact BFA Law about its investigation into potential claims for breach of fiduciary duty against Rapid7, Inc.
RPD INQUIRY UPDATE: Rapid7, Inc. (Nasdaq:RPD) Shareholders are Reminded to Contact BFA Law about Investigation into the Company’s Deal Price
July 08, 2024 07:11 ET
|
Bleichmar Fonti & Auld
Rapid7 Shareholders are encouraged to contact BFA Law about its investigation into potential claims for breach of fiduciary duty against Rapid7, Inc.
RPD INVESTIGATION NEWS: Rapid7, Inc. (Nasdaq:RPD) Investors are Notified to Contact BFA Law about Inquiry into the Company’s Purchase Price
July 06, 2024 06:20 ET
|
Bleichmar Fonti & Auld
Shareholders of Rapid7 are encouraged to contact BFA Law about its investigation into potential claims for breach of fiduciary duty against Rapid7, Inc.